Top 10 Traded US Stocks on POEMS in January 2021 February 10, 2021

Top 10 Traded US Stocks on POEMS in January 2021

At a glance:

  • All three US major indices were volatile in January, closing slightly lower except for NASDAQ Composite.
  • Electric-vehicle (EV) stocks remained traders’ top favourites due to their volatility and the industry’s promising future.
  • Tech stocks likely to sustain their momentum as NASDAQ Composite has been outperforming the other two indices.

Here are January’s top 10 traded US stocks on Phillip’s Online Electronic Mart System (POEMS), based on gross market value traded.

All three US major indices – Dow Jones, S&P 500 and NASDAQ Composite – made their new all-time highs in mid-January before closing lower towards the end of the month. The Dow stayed above 31,000 points most of the time, before dipping below 30,000. S&P 500 hit an all-time high of 3,860 while NASDAQ Composite traded comfortably above 13,000.

As the earnings season kicked off, we are expecting more market volatility. Reddit social- media users have been taking on Wall Street by short-squeezing hedge funds. We expect the tug-of-war between the amateur investors and hedge funds to fuel trading volumes further.

We have again included technical charts for all the top 10 counters. These are based on 4-hourly time frames over 30/40 days. The charts are for your information only. Support and resistance levels discussed are solely based on our dealers’ views. The technical charts should not be constituted as buy or sell recommendations and investors/traders are advised to do their own due diligence before making any trade.

Starting from the 10th position:

10th: Bionano Genomics (NASDAQ: BNGO)

From a low of US$0.50 on 1 December 2020, Bionano’s share price spiked over 2,100% to US$11.05 on 29 January 2021. It bulldozed its way into our top 10 traded list for the first time. The genomics company specialises in cytogenomics, which is the detection of genetic disorders by analysing differences in chromosomes.1

With ARK Invest hyping up the genomics sector, investors are jumping on the bandwagon in attempts to identify the next big thing. However, do note that with its declining revenue growth and rising costs, Bionano must dip into its cash reserves to sustain its operations.

The company had already raised funds twice in January. Further share issues are expected as it tries to take advantage of its record-high share price to beef up its cash position.

Top 10 Traded US Stocks on POEMS in January 2021

Technical Analysis:

Status: Technical Buy

Support: around US$11.20 (20-period moving average).

Resistance: around US$13.80 (previous high)

20-period moving average holding nicely as a support for uptrend.

9th: Li Auto Inc (NASDAQ: LI)

Li Auto dropped a spot to the ninth position in January. In a pool of increasingly overvalued EV stocks, Li Auto traded at around 11x consensus 2021 revenue vs. Nio’s 18.5x and Xpeng’s 19x projected 2021 revenue respectively.2

Li Auto’s lower valuation could be attributed to its narrower profit margins. A ramp-up of its manufacturing capacity should improve its profitability via economies of scale.

Li Auto sells hybrid vehicles that can be powered by gasoline. This lowers its dependence on EV-charging infrastructure, which is an advantage in China where commuting distances can be long.

Top 10 Traded US Stocks on POEMS in January 2021

Technical Analysis:

Status: Neutral

Support: around US$26.50 (recent low)

Resistance: around US$37.10 (recent triple top)

Appears to be range-bound. Possible short-term downtrend as 20-period MA crosses below 50-period MA. 20-period MA may be acting as immediate resistance.

8th: GameStop Corporation (NYSE: GME)

GameStop was the surprise addition to January’s top list. The stock was embroiled in a tug-of-war between social-media investors and hedge funds. It is now a symbol of the “uprising” against Wall Street elites.

When Reddit discovered that GameStop had over 140% short-selling interest, its community banded together to buy and hold its shares to trigger a short-squeeze. This led to massive losses of over US$5bn for short-sellers.3

GameStop’s share price has catapulted over 1,700% since the start of the year. The episode has highlighted to regulators the pitfalls of naked short-selling above stocks’ free floats.

Top 10 Traded US Stocks on POEMS in January 2021

Technical Analysis:

Status: Technical Sell

Support: around US$17 (previous low)

Resistance: US$110-120 (50-period moving average)

Technical analysis inconclusive due to the volatility of the counter.

7th: XPeng Inc (NYSE: XPEV)

Xpeng climbed two ranks to the 7th spot in January. The Chinese EV maker delivered 6,015 vehicles in January, up 470% year-on-year.

In January, Xpeng also launched a new version of its operating system, the Xmart OS 2.5.0, for its P7 sedan. The new OS adds over 40 new functions and now offers over 200 optimised features to users.4

The company has begun its overseas foray with the export of its G3 SUV to Norway. Norway has the largest EV fleet per capita in the world.5

Top 10 Traded US Stocks on POEMS in January 2021

Technical Analysis:

Status: Neutral

Support: around US$40.60 (previous low)

Resistance: around US$49 (20-period moving average)

Possible short-term downtrend formation (20-period MA crossing below 50-period MA).

6th: Alibaba Group Holding Ltd (NYSE: BABA)

2020 was a roller coaster year for Alibaba. The conglomerate managed to start 2021 in 6th position. Share price rallied about 15% in January as investors were optimistic about quarterly earnings on the back of its 11.11 sales and fast-growing cloud-computing division.6

However, Chinese regulators are cracking down on the tech giant with an anti-monopolistic investigation into its restrictions on merchants. They have also halted Ant’s IPO to prevent excessive lending to consumers.

The regulatory headwinds have dampened its share price but also provided buying opportunities for investors who continue to believe in the company’s business fundamentals.

Top 10 Traded US Stocks on POEMS in January 2021

Technical Analysis:

Status: Technical Buy

Support: around US$257 (50-period moving average)

Resistance: around US$270 (recent high)

Possible uptrend continuation. 50-period shown to be good support.

5th: Square Inc (NYSE: SQ)

Square tumbled to the fifth spot in January after its share price appeared to be heading towards a downtrend at the beginning of the year. Nevertheless, Robinhood’s recent woes surrounding buying restrictions over controversial stocks was a boon for Square.

More users have switched to Square’s Cash App – a platform that allows users to trade stocks – from the Robinhood backlash than to Stash, Fidelity or any other platform.7

Fears over Square’s exposure to small businesses and restaurants during the pandemic have been overshadowed by the growth of its Cash App. Besides stock-trading, Cash App allows users to transact digital cryptocurrencies. Bitcoin transactions accounted for US$1.63bn of Square’s net revenue in its September quarter.8

Top 10 Traded US Stocks on POEMS in January 2021

Technical Analysis:

Status: Neutral

Support: around US$226 (20-period moving average)

Resistance: around US$245 (recent double-top)

Appears to be range-bound as moving averages are criss-crossing.

4th: Palantir Technologies Inc (NYSE: PLTR)

Palantir surged from No. 8 last month to No. 4 in January. The data-analytics firm’s share price was muted in the first half of the month but inched its way up just before its Demo Day on 26 January.

Share price rose 18% to an all-time high of US$44 after the company’s product demonstrations. However, the joy was short-lived, with its price plunging soon after to close at US$35.55 on the last trading day of January.9

Top 10 Traded US Stocks on POEMS in January 2021

Technical Analysis:

Status: Technical Buy

Support: around US$31.50 (50-period moving average)

Resistance: around US$45 (recent high)

50-period shown to be a good support.

3rd: Apple Inc (NASDAQ: AAPL)

Apple has always been a staple in our top traded list. Hence, no surprise to see it in third spot in January. Stellar quarterly earnings on all-time record revenue of US$111.4bn cheered investors. Earnings per diluted share were US$1.68, up a good 35% year-on-year.10

Apple continues to lead the world in innovation and its latest M1 chip is expected to revolutionise the CPU market space.

Top 10 Traded US Stocks on POEMS in January 2021

Technical Analysis:

Support: around US$133.50 (uptrend line)

Resistance: around US$145 (recent high)

20-period MA staying above 50-period MA, suggesting intact uptrend.

2nd: Nio Inc (NYSE: NIO)

Nio maintained its second position for the second consecutive month. Investors bid up its shares ahead of its highly-anticipated annual Nio Day on 9 January.

Investors rubbed their hands with glee as Nio showcased its new product range and technologies, including a new flagship sedan using autonomous driving technology, during a lavish event over the weekend.

Its stock soared to a record US$66.99 on the following Monday on optimism over the company’s outlook.11Share price reversed after Nio Day to dip to US$57.01 on the last trading day of the month.

Top 10 Traded US Stocks on POEMS in January 2021

Technical Analysis:

Support: around US$55 (recent lows)

Resistance: around US$65-67 (recent high)

Support line at around US$55 seems to be holding.

1st: Tesla Motors Inc (NASDAQ: TSLA)

Still the undisputed top traded US stock on POEMS. The electric car maker has monopolised the top spot in six out of the previous eight months. You may explore our Market Journal series here on the past top 10 stocks.

Tesla shows no signs of slowing down.

Its inclusion in the S&P 500 index last December provided the catalyst for its share price to balloon from US$585 in December to over US$890 in January.12

That said, the company delivered mixed results in its latest report, with revenue beating consensus estimates but earnings falling behind.13

Top 10 Traded US Stocks on POEMS in January 2021

Technical Analysis:

Support: around US$830 (50-period moving average)

Resistance: around US$880-900 (recent highs)

Strong uptrend still unbroken. 50-period MA likely acting as stronger support.

Have a view on the above? Join our global investment community on Telegram and share your thoughts/views with us!.



These commentaries are intended for general circulation. It does not have regard to the specific investment objectives, financial situation and particular needs of any person who may receive this document. Accordingly, no warranty whatsoever is given and no liability whatsoever is accepted for any loss arising whether directly or indirectly as a result of any person acting based on this information. Opinions expressed in these commentaries are subject to change without notice. Investments are subject to investment risks including the possible loss of the principal amount invested. The value of the units and the income from them may fall as well as rise. Past performance figures as well as any projection or forecast used in these commentaries are not necessarily indicative of future or likely performance. Phillip Securities Pte Ltd (PSPL), its directors, connected persons or employees may from time to time have an interest in the financial instruments mentioned in these commentaries. Investors may wish to seek advice from a financial adviser before investing. In the event that investors choose not to seek advice from a financial adviser, they should consider whether the investment is suitable for them.

The information contained in these commentaries has been obtained from public sources which PSPL has no reason to believe are unreliable and any analysis, forecasts, projections, expectations and opinions (collectively the “Research”) contained in these commentaries are based on such information and are expressions of belief only. PSPL has not verified this information and no representation or warranty, express or implied, is made that such information or Research is accurate, complete or verified or should be relied upon as such. Any such information or Research contained in these commentaries are subject to change, and PSPL shall not have any responsibility to maintain the information or Research made available or to supply any corrections, updates or releases in connection therewith. In no event will PSPL be liable for any special, indirect, incidental or consequential damages which may be incurred from the use of the information or Research made available, even if it has been advised of the possibility of such damages. The companies and their employees mentioned in these commentaries cannot be held liable for any errors, inaccuracies and/or omissions howsoever caused. Any opinion or advice herein is made on a general basis and is subject to change without notice. The information provided in these commentaries may contain optimistic statements regarding future events or future financial performance of countries, markets or companies. You must make your own financial assessment of the relevance, accuracy and adequacy of the information provided in these commentaries.

Views and any strategies described in these commentaries may not be suitable for all investors. Opinions expressed herein may differ from the opinions expressed by other units of PSPL or its connected persons and associates. Any reference to or discussion of investment products or commodities in these commentaries is purely for illustrative purposes only and must not be construed as a recommendation, an offer or solicitation for the subscription, purchase or sale of the investment products or commodities mentioned.

About the author

Joel Lim (ETF Specialist) & Chuang Ming Jun (Senior Dealer)

Joel graduated from Singapore Institute of Management, University of London with a First-Class Honours in Business. He was the recipient of SIM University of London’s Top Student Bronze Award in 2017 and was the worldwide examination topper for the “Financial Management” module in 2016. Joel was also commended by University of London for his excellent performance in the 2014 Examinations.

Joel is involved in ETF education, providing trading ideas and support to traders, dealers and fund managers. Joel also works closely with ETF issuers to educate retail investors about new ETFs during the Initial Offering Period.

Ming Jun graduated from RMIT with a Bachelor’s Degree in Business Management. He joined Phillip Securities in 2016 as an Equity Dealer and is currently with the Global Markets Night Trading Team, specialising in the UK and Europe markets, as well as supporting the US and Canada markets. . He has provided regular market commentaries across various media channels such as Morning Express Channel 8, 95.8FM Live Radio, and 联合早报.

Contact us to Open an Account

Need Assistance? Share your Details and we’ll get back to you


This material is provided by Phillip Capital Management (S) Ltd (“PCM”) for general information only and does not constitute a recommendation, an offer to sell, or a solicitation of any offer to invest in any of the exchange-traded fund (“ETF”) or the unit trust (“Products”) mentioned herein. It does not have any regard to your specific investment objectives, financial situation and any of your particular needs. You should read the Prospectus and the accompanying Product Highlights Sheet (“PHS”) for key features, key risks and other important information of the Products and obtain advice from a financial adviser (“FA“) pursuant to a separate engagement before making a commitment to invest in the Products. In the event that you choose not to obtain advice from a FA, you should assess whether the Products are suitable for you before proceeding to invest. A copy of the Prospectus and PHS are available from PCM, any of its Participating Dealers (“PDs“) for the ETF, or any of its authorised distributors for the unit trust managed by PCM.  

An ETF is not like a typical unit trust as the units of the ETF (the “Units“) are to be listed and traded like any share on the Singapore Exchange Securities Trading Limited (“SGX-ST”). Listing on the SGX-ST does not guarantee a liquid market for the Units which may be traded at prices above or below its NAV or may be suspended or delisted. Investors may buy or sell the Units on SGX-ST when it is listed. Investors cannot create or redeem Units directly with PCM and have no rights to request PCM to redeem or purchase their Units. Creation and redemption of Units are through PDs if investors are clients of the PDs, who have no obligation to agree to create or redeem Units on behalf of any investor and may impose terms and conditions in connection with such creation or redemption orders. Please refer to the Prospectus of the ETF for more details.  

Investments are subject to investment risks including the possible loss of the principal amount invested. The purchase of a unit in a fund is not the same as placing your money on deposit with a bank or deposit-taking company. There is no guarantee as to the amount of capital invested or return received. The value of the units and the income accruing to the units may fall or rise. Past performance is not necessarily indicative of the future or likely performance of the Products. There can be no assurance that investment objectives will be achieved.  

Where applicable, fund(s) may invest in financial derivatives and/or participate in securities lending and repurchase transactions for the purpose of hedging and/or efficient portfolio management, subject to the relevant regulatory requirements. PCM reserves the discretion to determine if currency exposure should be hedged actively, passively or not at all, in the best interest of the Products.  

The regular dividend distributions, out of either income and/or capital, are not guaranteed and subject to PCM’s discretion. Past payout yields and payments do not represent future payout yields and payments. Such dividend distributions will reduce the available capital for reinvestment and may result in an immediate decrease in the net asset value (“NAV”) of the Products. Please refer to <> for more information in relation to the dividend distributions.  

The information provided herein may be obtained or compiled from public and/or third party sources that PCM has no reason to believe are unreliable. Any opinion or view herein is an expression of belief of the individual author or the indicated source (as applicable) only. PCM makes no representation or warranty that such information is accurate, complete, verified or should be relied upon as such. The information does not constitute, and should not be used as a substitute for tax, legal or investment advice.  

The information herein are not for any person in any jurisdiction or country where such distribution or availability for use would contravene any applicable law or regulation or would subject PCM to any registration or licensing requirement in such jurisdiction or country. The Products is not offered to U.S. Persons. PhillipCapital Group of Companies, including PCM, their affiliates and/or their officers, directors and/or employees may own or have positions in the Products. Any member of the PhillipCapital Group of Companies may have acted upon or used the information, analyses and opinions herein before they have been published. 

This advertisement has not been reviewed by the Monetary Authority of Singapore.  


Phillip Capital Management (S) Ltd (Co. Reg. No. 199905233W)  
250 North Bridge Road #06-00, Raffles City Tower ,Singapore 179101 
Tel: (65) 6230 8133 Fax: (65) 65383066